David Clair News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES

MINNEAPOLIS, May 31, 2024 /PRNewswire/ Bio-Techne Corporation today announced that Kim Kelderman, President and Chief Executive Officer will present at the following investor.

William blairKim keldermanDavid clairInvestor relations corporate developmentBio techne corporationGoldman sachsPrnewswire bio techne corporationTechne corporationChief executive officerAnnual growthAnnual global healthcareInvestor relationsVice president

BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE

BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Anaheim convention centerUnited statesDavid clairChris hegerSara carilloInvestor relations corporate developmentNational institute for bioprocessing researchBio techne corporationPrnewswire bio techne corporationProtein sciences segmentTechne corporationMass spectrometryAllied topicsProtein charge heterogeneity characterizationAnaheim conventionNational institute

BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE

/PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer will present at the 2024.

David clairKim keldermanBio techne corporationInvestor relations corporate developmentChief executive officerPartners healthcare crossroads conferenceInvestor relationsTechne corporationVice president

BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY S PROPRIETARY TECHNOLOGY

MINNEAPOLIS, May 22, 2024 /PRNewswire/ Bio-Techne Corporation and Regulus Therapeutics Inc., a biopharmaceutical company focused on the discovery and development of innovative medicines.

San diegoUnited statesBio techne exosomedxCris calsadaDavid clairSarah suttonBio techne corporationPrnewswire bio techne corporationRegulus therapeutics incProtein sciences segmentInvestor relations corporate developmentTechne corporationAutosomal dominant polycystic kidney diseaseSimple westernWill geistProtein sciences

Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript

Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.48, expectations were $0.46.

South koreaUnited statesJim hippelWilliam blairKim keldermanCatherine schulteMatt larewPuneet soudaWilson wolfPatrick donnellyJacob johnsonBio techne rnascope hiplexDavid clairJustin bowersDan ariasOur protein sciences